Mary McPhillips

768 total citations
19 papers, 441 citations indexed

About

Mary McPhillips is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Mary McPhillips has authored 19 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Mary McPhillips's work include Genetic factors in colorectal cancer (15 papers), Colorectal Cancer Screening and Detection (9 papers) and Cancer Genomics and Diagnostics (8 papers). Mary McPhillips is often cited by papers focused on Genetic factors in colorectal cancer (15 papers), Colorectal Cancer Screening and Detection (9 papers) and Cancer Genomics and Diagnostics (8 papers). Mary McPhillips collaborates with scholars based in Australia, Norway and Poland. Mary McPhillips's co-authors include Rodney J. Scott, Cliff Meldrum, Allan D. Spigelman, Judy Kirk, Desirée du Sart, Patrick Fitzgerald, Kathy Tucker, Bente A. Talseth‐Palmer, AD Spigelman and John W. Patrick and has published in prestigious journals such as PLoS ONE, The American Journal of Human Genetics and International Journal of Cancer.

In The Last Decade

Mary McPhillips

18 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary McPhillips Australia 10 339 200 179 112 100 19 441
Jeff Bacher United States 7 206 0.6× 127 0.6× 129 0.7× 77 0.7× 41 0.4× 8 312
Melya J. Hughes Switzerland 7 442 1.3× 156 0.8× 215 1.2× 404 3.6× 100 1.0× 7 582
Mario A. Hermsen Netherlands 2 145 0.4× 98 0.5× 105 0.6× 112 1.0× 116 1.2× 2 301
Raffaella Liccardo Italy 11 227 0.7× 144 0.7× 161 0.9× 118 1.1× 43 0.4× 23 330
Antonia M. Fernández‐Peralta Spain 10 140 0.4× 136 0.7× 99 0.6× 91 0.8× 47 0.5× 29 312
Kanade Katsura Japan 9 102 0.3× 67 0.3× 85 0.5× 137 1.2× 59 0.6× 22 310
Heikki Järvinen Finland 3 439 1.3× 311 1.6× 184 1.0× 128 1.1× 81 0.8× 3 487
D. Nguyen United States 4 252 0.7× 155 0.8× 158 0.9× 209 1.9× 37 0.4× 7 356
Cassandra Gulden United States 5 158 0.5× 114 0.6× 148 0.8× 66 0.6× 117 1.2× 7 280
Eiitsu Nakajima Japan 8 357 1.1× 130 0.7× 166 0.9× 318 2.8× 55 0.6× 11 467

Countries citing papers authored by Mary McPhillips

Since Specialization
Citations

This map shows the geographic impact of Mary McPhillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary McPhillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary McPhillips more than expected).

Fields of papers citing papers by Mary McPhillips

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary McPhillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary McPhillips. The network helps show where Mary McPhillips may publish in the future.

Co-authorship network of co-authors of Mary McPhillips

This figure shows the co-authorship network connecting the top 25 collaborators of Mary McPhillips. A scholar is included among the top collaborators of Mary McPhillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary McPhillips. Mary McPhillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Connor, Thomas M., Mary McPhillips, Andrew Ziolkowski, et al.. (2021). CD36 polymorphisms and the age of disease onset in patients with pathogenic variants within the mutation cluster region of APC. Hereditary Cancer in Clinical Practice. 19(1). 25–25. 3 indexed citations
2.
Singh, Ashish, Bente A. Talseth‐Palmer, Mary McPhillips, et al.. (2020). Targeted sequencing of genes associated with the mismatch repair pathway in patients with endometrial cancer. PLoS ONE. 15(7). e0235613–e0235613. 4 indexed citations
3.
Ziolkowski, Andrew, et al.. (2020). Novel de novo TRIP12 mutation reveals variable phenotypic presentation while emphasizing core features of TRIP12 variations. American Journal of Medical Genetics Part A. 182(7). 1801–1806. 4 indexed citations
4.
Wong‐Brown, Michelle W., Mary McPhillips, Margaret Gleeson, et al.. (2016). When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans. Hereditary Cancer in Clinical Practice. 14(1). 6–6. 4 indexed citations
5.
Sjursen, Wenche, Mary McPhillips, Rodney J. Scott, & Bente A. Talseth‐Palmer. (2016). Lynch syndrome mutation spectrum in New South Wales, Australia, including 55 novel mutations. Molecular Genetics & Genomic Medicine. 4(2). 223–231. 15 indexed citations
6.
Talseth‐Palmer, Bente A., Denis C. Bauer, Wenche Sjursen, et al.. (2016). Targeted next‐generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families. Cancer Medicine. 5(5). 929–941. 19 indexed citations
7.
Talseth‐Palmer, Bente A., Juul Wijnen, Shantie Jagmohan–Changur, et al.. (2012). Combined analysis of three lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers. International Journal of Cancer. 132(7). 1556–1564. 20 indexed citations
8.
Talseth‐Palmer, Bente A., Juul Wijnen, Shantie Jagmohan–Changur, et al.. (2012). Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts. Hereditary Cancer in Clinical Practice. 10(Suppl 2). A32–A32.
9.
Talseth‐Palmer, Bente A., et al.. (2010). MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer. Hereditary Cancer in Clinical Practice. 8(1). 5–5. 32 indexed citations
10.
Talseth‐Palmer, Bente A., Katie A. Ashton, Tiffany‐Jane Evans, et al.. (2010). Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome. Journal of Medical Genetics. 48(4). 279–284. 29 indexed citations
11.
Ashton, Katie A., Cliff Meldrum, Mary McPhillips, et al.. (2006). The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria. Hereditary Cancer in Clinical Practice. 4(2). 94–94. 8 indexed citations
12.
Ashton, Katie A., et al.. (2005). Frequency of the Common MYH Mutations (G382D and Y165C) in MMR Mutation Positive and Negative HNPCC Patients. Hereditary Cancer in Clinical Practice. 3(2). 65–70. 11 indexed citations
13.
McPhillips, Mary, et al.. (2005). Deletion Mutations in an Australian Series of HNPCC Patients. Hereditary Cancer in Clinical Practice. 3(1). 43–7. 2 indexed citations
14.
Thompson, Ella R., Cliff Meldrum, Renee Crooks, et al.. (2004). Hereditary non‐polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations. Clinical Genetics. 65(3). 215–225. 41 indexed citations
15.
16.
Scott, Rodney J., Renee Crooks, Cliff Meldrum, et al.. (2002). Mutation analysis of the STK11/LKB1 gene and clinical characteristics of an Australian series of Peutz–Jeghers syndrome patients. Clinical Genetics. 62(4). 282–287. 46 indexed citations
17.
Scott, Rodney J., Mary McPhillips, Cliff Meldrum, et al.. (2001). Hereditary Nonpolyposis Colorectal Cancer in 95 Families: Differences and Similarities between Mutation-Positive and Mutation-Negative Kindreds. The American Journal of Human Genetics. 68(1). 118–127. 152 indexed citations
18.
McPhillips, Mary, et al.. (2000). Hexose transporters of tomato: molecular cloning, expression analysis and functional characterization. Plant Molecular Biology. 44(5). 687–697. 49 indexed citations
19.
Shealy, Y. Fulmer, James M. Riordan, Donald L. Hill, et al.. (1997). Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancer.. PubMed. 12(1). 15–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeff Bacher Breakdown of academic impact, for papers by Melya J. Hughes Breakdown of academic impact, for papers by Mario A. Hermsen Breakdown of academic impact, for papers by Raffaella Liccardo Breakdown of academic impact, for papers by Antonia M. Fernández‐Peralta Breakdown of academic impact, for papers by Kanade Katsura Breakdown of academic impact, for papers by Heikki Järvinen Breakdown of academic impact, for papers by D. Nguyen Breakdown of academic impact, for papers by Cassandra Gulden Breakdown of academic impact, for papers by Eiitsu Nakajima
Rankless by CCL
2026